Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
HAE · against 226 other Healthcare companies of similar size
Ranked #113 of 227 · scores higher than 50% of peers
Bars: peers in each 10-point band of the valuation score32 peers with a valuation score of 50–59, including HAE · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | HAE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 224 reported | 1.7% | 2.4% | 44% | 30% | |
| EBITDA yieldHigher is better · 224 reported | 5.6% | 4.5% | 59% | 50% | |
| Free cash flow yieldHigher is better · 130 reported | 5.3% | 1.0% | 83% | 20% | |
| Book yieldHigher is better · 225 reported | 15.3% | 25.2% | 33% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 4 | 22.0B CNY (≈$3.1B) | 96 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 107 | 3.0B USD | 55 | 39 | |
| 107 | 9.3B USD | 55 | 64 | |
| 112 | 5.8B USD | 54 | 68 | |
| 113 | 21.5B DKK (≈$3.2B) | 53 | 58 | |
| 113 | 5.5B USD | 53 | 43 | |
| 115 | 49.0B CNY (≈$6.9B) | 52 | 60 | |
| 115 | 10.0B USD | 52 | 43 | |
| 115 | 9.3B AUD (≈$6.1B) | 52 | 55 | |
| 118 | 6.1B CHF (≈$7.0B) | 51 | 58 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score